Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21

Journal of Hypertension

Volumn 29, Issue 8, 2011, Pages 1560-1568

  Zhang, Ye ^a,b   Wang, Yan ^c   Wang, Xukai ^a,b   Zhang, Yi ^d   Eisner, Gilbert M ^e   Asico, Laureano D ^f   Jose, Pedro A ^f   Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Cardiology   (China)

^c Department of Medical Genetics ^*  (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

insulin; microRNA; p21; proliferation; vascular smooth muscle cells

Indexed keywords

INSULIN; MICRORNA; MICRORNA 208; PROTEIN P21; RNA; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 79960580410     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328348ef8e     Document Type: Article

References (35)

1. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
2. Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 1991; 90:62S-65S.
3. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-194.
4. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36:319-327.
5. Pfeifle B, Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981; 20:155-158. (Pubitemid 11138479)
6. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355. (Pubitemid 39265675)
7. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
8. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20. (Pubitemid 40094598)
9. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. Atherosclerosis:a cancer of the blood vessels? Am J Clin Pathol 2001; 116:S97-S107.
10. Sanada H, Asico LD, Shigetomi S, Tanaka K, Niimura S, Watanabe H. The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats. Clin Exp Hypertens 2000; 22:419-429. (Pubitemid 30327375)
11. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 2008; 214:434-441. (Pubitemid 350309000)
12. Castoldi M, Schmidt S, Benes V, Hentze MW, Muckenthaler MU. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat Protoc 2008; 3:321-329. (Pubitemid 351266516)
13. Zhang B, Wang X, Wang Y. Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. J Exp Clin Cancer Res 2009; 28:56.
14. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNAtarget recognition. PLoS Biol 2005; 3:e85.
15. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, et al. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 2006; 99:494-500. (Pubitemid 44337821)
16. Doench JG, Petersen CP, Sharp PA. SiRNAs can function as miRNAs. Genes Dev 2003; 17:438-442. (Pubitemid 36258757)
17. Kim HS, Cho HJ, Cho HJ, Park SJ, Park KW, Chae IH, et al. The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell. J Mol Cell Cardiol 2004; 37:871-880.
18. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, et al. MicroRNAmediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173:242-252. (Pubitemid 351947971)
19. He X, Duan C, Chen J, Ou-Yang X, Zhang Z, Li C, Peng H. Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett 2009; 583:3501-3507.
20. Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik AE, Hentze MW, Muckenthaler MU. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 2006; 12:913-920.
21. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007; 101:59-68. (Pubitemid 47094624)
22. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that downregulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111:1217-1226. (Pubitemid 351213403)
23. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100:1164-1173. (Pubitemid 46684129)
24. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006; 108:3068-3071.
25. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, et al. The human angiotensin II type 1 receptor t1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 2007; 282:24262-24269. (Pubitemid 47328062)
26. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. Expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100:1579-1588. (Pubitemid 46897261)
27. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008; 105:1516-1521. (Pubitemid 351346546)
28. Van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007; 316:575-579. (Pubitemid 46683138)
29. Xu CC, Han WQ, Xiao B, Li NN, Zhu DL, Gao PJ. Differential expression of microRNAs in the aorta of spontaneously hypertensive rats. Sheng Li Xue Bao 2008; 60:553-560.
30. Jacks T, Weinberg RA. Cell-cycle control and its watchman. Nature 1996; 381:643-644. (Pubitemid 26196558)
31. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551-555. (Pubitemid 24363798)
32. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998; 82:396-403. (Pubitemid 28101197)
33. Jeon EM, Choi HC, Lee KY, Chang KC, Kang YJ. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch Pharm Res 2009; 32: 375-382.
34. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 1996; 93:7905-7910. (Pubitemid 26277137)
35. Okamoto H, Fujioka Y, Takahashi A, Takahashi T, Taniguchi T, Ishikawa Y, et al. an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). J Atheroscler Thromb 2006; 13:183-191.